Dunning R3327-G prostate carcinoma of the rat: an appropriate model for drug evaluation

This publication has 12 references indexed in Scilit:

• Beneficial effects of androgen-primed chemotherapy in the Dunning R3327 G model of prostatic cancer.
  1991
• Effect of zindoxifene on experimental prostatic tumours of the rat
  Zeitschrift für Krebsforschung und Klinische Onkologie, 1991
• Carrier mediated action of platinum complexes on estrogen receptor positive tumors
  European Journal of Cancer and Clinical Oncology, 1989
• [1, 2-bis (2, 6-dichloro-4-hydroxyphenyl) ethylenediamine]dichloro-platinum(II): An endocrine-active platinum complex with a specific prostatic tumor-inhibiting activity
  The Prostate, 1989
• Antitumor activity of antiestrogenic phenylindoles on experimental prostate tumors
  European Journal of Cancer and Clinical Oncology, 1987
• UNUSUAL ANDROGEN SENSITIVITY OF THE ANDROGEN-INDEPENDENT DUNNING R-3327-G RAT PROSTATIC ADENOCARCINOMA - ANDROGEN EFFECT ON TUMOR-CELL LOSS
  1982
• HORMONE SENSITIVITY OF THE R3327-G RAT PROSTATE ADENOCARCINOMA - GROWTH-RATE, DNA CONTENT, AND HORMONE RECEPTORS
  1982
• Flow cytometric analysis of the response of the r3327-g rat prostatic adenocarcinoma to endocrine manipulation
  Journal of Surgical Oncology, 1981
• Animal models of the hormone-sensitive and -insensitive prostatic adenocarcinomas, Dunning R-3327-H, R-3327-HI, and R-3327-AT.
  1978
• Characterization of the Dunning R3327H prostatic adenocarcinoma: an appropriate animal model for prostatic cancer.
  1977